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OBJECTIVE: To investigate the recognition of depressive symptoms of major depressive disorder (MDD) by general practitioners. 
INTRODUCTION: MDD is underdiagnosed in medical settings, possibly because of difficulties in the recognition of specific 
depressive symptoms.
METHODS: A cross-sectional study of 316 outpatients at their first visit to a teaching general hospital. We evaluated the performance 
of 19 general practitioners using Primary Care Evaluation of Mental Disorders (PRIME-MD) to detect depressive symptoms and 
compared them to 11 psychiatrists using Structured Clinical Interview Axis I Disorders, Patient Version (SCID I/P). We measured 
likelihood ratios, sensitivity, specificity, and false positive and false negative frequencies.
RESULTS: The lowest positive likelihood ratios were for psychomotor agitation/retardation (1.6) and fatigue (1.7), mostly because 
of a high rate of false positive results. The highest positive likelihood ratio was found for thoughts of suicide (8.5). The lowest 
sensitivity, 61.8%, was found for impaired concentration. The sensitivity for worthlessness or guilt in patients with medical illness 
was 67.2% (95% CI, 57.4-76.9%), which is significantly lower than that found in patients without medical illness, 91.3% (95% 
CI, 83.2-99.4%). 
DISCUSSION: Less adequately identified depressive symptoms were both psychological and somatic in nature. The presence of 
a medical illness may decrease the sensitivity of recognizing specific depressive symptoms. 
CONCLUSIONS: Programs for training physicians in the use of diagnostic tools should consider their performance in recognizing 
specific depressive symptoms. Such procedures could allow for the development of specific training to aid in the detection of the 
most misrecognized depressive symptoms. 
KEYWORDS: Internal medicine; Ambulatory care; Diagnosis; Depressive disorder; Primary care.
INTRODUCTION
Major depressive disorder (MDD) has been associated 
with increased morbidity1and mortality,2 and is highly 
prevalent in primary care.3 Several initiatives to improve the 
recognition and treatment of depression by physicians have 
been successful;4-9 however, there is still significant evidence 
for the underdiagnosis of depression in primary care.4,10 
In addition to time constraints during the consultation 
and aspects related to physician training,7,11 several 
characteristics of depression may make its recognition 
difficult. For example, depression has been reported to be 
less likely to be recognized and diagnosed in patients who 
present somatic symptoms than in patients who present 
predominantly psychological symptoms.10,12 In contrast, the 
presence of medically unexplained somatic symptoms and 
hypochondriac worries have been reported to increase the 
rate of diagnosis.12 These studies suggest that recognition 
of certain depressive symptoms may be more difficult than 
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others. We are not aware of any study that has specifically 
investigated this topic. Thus, this study was developed to 
investigate recognition of depressive symptoms of MDD 
by physicians using Primary Care Evaluation of Mental 
Disorders (PRIME-MD).13 The physicians’ evaluations were 
compared to the evaluations of psychiatrists using Structured 
Clinical Interview Axis I, Patient Version (SCID-I/P).14 
METHODS
Subjects
A total of 577 patients were evaluated for depression by 
their general practitioner, of whom 316 were also evaluated 
by a psychiatrist. This report includes all 316 subjects seen 
by both a general practitioner and a psychiatrist, in contrast 
to our previously published manuscript15 that included 
240 subjects after excluding patients with missing data on 
medical status, health service utilization, and diagnostic 
criteria for MDD. 
The 316 patients in this study were 18 years or older with 
a mean age of 40.8 (+14.8) years. Most were female (74%), 
married or living with a partner (51.3%), and had five or less 
years of education (55.8%). Except for higher rates of female 
gender and presence of medical illness, the group studied did 
not differ from the remaining 261 patients of the original sample 
of 577 subjects that were not included in this report (Table 1). 
We excluded patients that could not comprehend the questions 
and patients with health problems that limited the interview. 
We examined the recognition of depressive symptoms by 
general practitioners in a cross sectional two-phase study at a 
teaching general outpatient unit (Ambulatório Geral Didático 
- AGD) of the Clinical Hospital of the Faculty of Medicine, 
Sao Paulo University (HC-FMUSP), São Paulo, Brazil. 
Details of the protocol have been published previously in 
a study focusing on the validity of diagnosing MDD and 
subsyndromal depression.15 Briefly, 577 patients on their 
first visit to the outpatient unit were consecutively evaluated 
by the physician using Primary Care Evaluation of Mental 
Disorders (PRIME-MD).13 All patients with the diagnosis 
of MDD and a random sub-sample of those without MDD 
(odds of referral 1:4) were subsequently evaluated by 
a psychiatrist using SCID-I/P for DSM-IV disorders.14 
The psychiatric evaluation was blinded and carried out 
immediately after the evaluation by the physicians. All 
patients signed a written informed consent form before being 
included in the study. The research protocol was approved 
by the Institutional Review Board of the Clinical Hospital of 
the Faculty of Medicine, Sao Paulo University HC-FMUSP.
A team of 11 psychiatrists and 19 physicians were 
recruited and trained. Two psychiatrists (RF and SGH) trained 
the physicians in PRIME-MD for DSM-III-R13 in a four-hour 
training program. The psychiatrists were trained by one of the 
authors (RF) in a six-hour program. All professionals received 
payment in currency for their work. All evaluations were 
carried out at the General Medicine Outpatient Unit.
Table 1 - Sociodemographic characteristics of the subjects, and comparison between patients interviewed by psychiatrists 
(n=316, included in this report) and those not interviewed by psychiatrists (n=261, not included in this report)
Characteristics
Original sample (n=577)
p-value
Studied group Group not included in this study
n= 316 % n= 261 %
Gender
Female
Marital Status
Married/living with a partner
Never married
Divorced/separated/widowed
Not declared
Educational Level (years)
 0
 1-5
 6-10
 More than 12
Medical Disease
Yes
No
Mean age (years) (+ S.D.)
234
162
68
57
29
16
114
71
32
205
109
40.8
74.0
51.3
21.5
18.0
9.2
6.9
48.9
30.5
13.7
65.3
34.7
14.8
170
132
70
42
17
21
98
42
26
138
123
41.4
65.1
50.6
27.8
16.1
6.5
11.2
52.4
22.5
13.9
52.9
47.1
16.0
0.020a
 
 0.476b
 0.174 b 
0.003 a
0.323c
a
 Pearson’s Chi-square test (χ2), d.f.=1; b Pearson’s Chi-square test (χ2), d.f.=3; c Student’s t-test; SD = standard deviation
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PRIME-MD for DSM-III-R, although comprised of 
structured questions, permits further investigation and 
inquiries according to the judgment of the interviewer. It 
is divided into five modules (mood, anxiety, somatoform, 
alcohol and eating disorders) covering the most common 
disorders found in primary care. Nine questions investigate 
the main depressive symptoms and the presence of MDD 
according to the DSM-III-R criteria. All diagnoses were 
determined from the questionnaire by answers of ‘yes’ or 
‘no’.13 PRIME-MD was translated into Portuguese by two 
of the authors (RF and SGHJ). The Portuguese version 
was back-translated into English and submitted for the 
approval of the author (Dr. Spitzer), whose suggestions 
were incorporated into the final Portuguese version. For the 
present study, we utilized the answers to the PRIME-MD 
mood module (which covers the diagnosis of MDD). The 
answers to the psychiatrist-administered SCID I/P14 were 
used as a comparison. The mood modules of PRIME-MD 
and SCID I/P cover the same DSM-III-R items for the 
diagnosis of MDD. The physicians evaluated the presence 
of a medical illness by an open interview and a check list 
with 13 possible categories of medical illness including: 
cardiovascular, infectious, endocrine, neurological, 
rheumatic, gastrointestinal, dermatologic, musculoskeletal, 
gynecologic, oncological, allergic, and immunologic 
illnesses. For this study, we included all subjects having any 
medical condition in any of the 13 categories in the group 
with medical illness(es). 
The statistical analysis was performed to investigate three 
aspects: 1- The ability of the physicians to recognize each 
depressive symptom; 2- The influence of a medical illness 
on the recognition of each depressive symptom; and 3- The 
influence of gender on the recognition of each depressive 
symptom.
Following the SCID I/P guidelines, we counted 
symptoms coded “3” (threshold) as present and symptoms 
coded “1” or “2” as absent. 
To investigate the performance of the physicians at 
recognizing each depressive symptom, we calculated 
sensitivity, specificity, false positives and negatives, 
true positives and negatives, and positive and negative 
likelihood ratios for each depressive symptom evaluated 
by the physicians using PRIME-MD and compared them 
to the evaluations of the psychiatrists using SCID I/P 
(standard criteria). The positive likelihood ratio is defined 
as the likelihood of a positive evaluation of a depressive 
symptom in a patient with the symptom divided by the 
likelihood of a positive evaluation in a patient without 
that depressive symptom. For example, let us consider the 
symptom of insomnia and the hypothetical situation in 
which the physicians correctly detect 90% of the patients 
with true insomnia (sensitivity), and incorrectly detect 15% 
of the subjects without insomnia as having insomnia (false 
positive=1-specificity). The physicians were six times as 
likely to recognize a patient with insomnia as opposed to 
a patient without insomnia (i.e., 90 divided by 15), which 
is the likelihood ratio for a positive test result. We chose 
the likelihood ratio as it is not influenced by symptom 
prevalence, thus allowing for a closer evaluation of physician 
performance.
To investigate the influence of patient gender and the 
presence of medical illness on the recognition of depressive 
symptoms, we measured specificity and sensitivity for each 
depressive symptom separately in four groups defined by 
gender and the presence or absence of medical disease. 
Analyses were performed using Stata version 8.2 for 
Windows. The accepted two-sided significance level was 
alpha 0.05. Given the preliminary nature of this study, we 
did not use adjustments for multiple comparisons. 
RESULTS
In this study, which compared the performance of 
physicians using PRIME-MD to identify depressive 
symptoms in 316 outpatients to that of psychiatrists using 
SCID, we found the lowest sensitivities for the symptoms of 
impaired concentration (61.8%), appetite or weight change 
(72.2%), and insomnia or hypersomnia (74.1%) (Table 
2). False negative results were particularly common for 
impaired concentration (n=68), depressed mood (n=53), and 
appetite or weight changes (n=52) (Table 2).
The depressive symptoms with the lowest positive 
likelihood ratios were psychomotor agitation/retardation 
(1.6) and fatigue (1.7) (Table 2).
The symptom with the lowest sensitivity for females 
and males both with and without medical conditions was 
impaired concentration (Tables 3 and 4). Thoughts of death/
suicide was the symptom with the greatest difference in the 
sensitivity between males and females, 68.1% vs. 77.0% 
(Table 3), respectively. Even in this case, the confidence 
intervals for the two genders overlapped, indicating that the 
difference was not statistically significant.
Although most of the confidence intervals overlapped, 
the sensitivity for almost all of the depressive symptoms was 
numerically lower in the group with medical disease than 
in the group without medical disease. The exception was 
“thoughts of death,” which were more readily detected by 
physicians in subjects with medical illnesses. The sensitivity 
for worthlessness or guilt exhibited the greatest difference 
between patients with or without medical disease, 67.2% 
vs. 91.3%, respectively. The difference was statistically 
significant (Table 4). 
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DISCUSSION
Using 316 subjects from an outpatient unit of a teaching 
general hospital, we investigated the performance of general 
practitioners using PRIME-MD to recognize depressive 
symptoms of MDD and compared their performance to 
that of psychiatrists using SCID I/P. Of note, the highest 
likelihood ratio was 8.5 for thoughts of suicide. Although 
it did not achieve the level considered to be strong 
clinical evidence of the presence of a symptom (above 
10, as proposed by Deeks, 2004),16 this result encourages 
physicians to investigate suicidal ideation. On the other 
hand, the lowest positive likelihood ratios were for fatigue 
and psychomotor agitation/retardation. The sensitivities for 
these symptoms were relatively high. In addition, a high rate 
of false positives (i.e. physicians frequently considered these 
symptoms present when they, in fact, were absent) but not 
false negatives was found. This relatively high sensitivity 
for fatigue and psychomotor agitation/retardation contrasts 
with previous studies in which physicians had lower rates 
Table 2 - Primary care physicians’ recognition of depressive symptoms: sensitivity, specificity, true positive, true negative, 
false positive, false negative, positive and negative likelihood ratios (n= 316)
Depressive symptoms sensitivity 95% CI specificity 95% CI True 
positive
True 
negative
False 
positive
False 
negative
Positive
likelihood
ratio
Negative
likelihood
ratio
Depressed mood 72.9 (67.3 - 78.5) 70.4 (57.2 - 83.6) 176 27 14 53 2.5 0.4
Loss of interest/pleasure 77.3 (71.7 - 82.9) 61.1 (50.0 - 72.1) 166 41 29 44 2.0 0.4
Appetite/weight change 72.2 (66.0 - 78.3) 85.4 (78.1 - 92.7) 140 73 13 52 4.9 0.3
Insomnia/hypersomnia 74.1 (67.9 - 80.3) 75.0 (66.6 - 83.3) 134 75 25 47 3.0 0.3
Psychomotor agitation/
retardation
80.0 (73.0 - 87.0) 48.5 (40.4 - 56.6) 98 60 68 23 1.6 0.4
Fatigue 84.5 (79.9 - 89.1) 50.0 (37.3 - 62.6) 199 28 30 34 1.7 0.3
Worthlessness/guilt 75.4 (68.4 - 82.5) 61.4 (53.5 - 69.3) 101 83 52 33 2.0 0.4
Impaired concentration 61.8 (55.0 - 68.6) 76.2 (67.7 - 84.7) 109 71 22 68 2.6 0.5
Thoughts of death/suicide 77.0 (68.3 - 85.6) 90.9 (86.6 - 95.2) 63 159 15 20 8.5 0.3
CI = confidence interval 
Table 3 - Primary care physicians’ recognition of depressive symptoms: sensitivity and specificity according to gender (n= 316)
Female  Male
Depressive symptoms Sensitivity 95% CI Specificity 95% CI Sensitivity 95% CI Specificity 95% CI
Depressed mood 75.7 (69.3-82.0) 61.2 (48.1-74.2) 78.8 (67.7-89.9) 66.7 (49.8-83.5)
Loss of interest/pleasure 77.5 (71.3-83.8) 52.0 (39.6-64.4) 84.6 (73.3-95.9) 60.5 (45.9-75.1)
Appetite/weight change 71.1 (63.7-78.6) 73.1 (63.9-82.3) 76.6 (64.6-88.6) 79.2 (65.5-92.9)
Insomnia/hypersomnia 77.3 (70.4-84.3) 65.5 (56.0-75.0) 65.9 (51.3-80.4) 65.9 (51.3-80.4)
Psychomotor agitation/retardation 81.3 (73.6-89.1) 40.9 (32.6-49.2) 80.0 (64.3-95.7) 54.4 (41.5-67.3)
Fatigue 85.7 (80.6-90.8) 42.3 (28.9-55.7) 84.3 (74.3-94.3) 48.4 (30.8-66.0)
Worthlessness/guilt 74.8 (66.7-83.0) 55.0 (46.2-63.7) 76.4 (59.9-92.9) 60.1 (47.3-72.9)
Impaired concentration 61.6 (53.6-69.5) 67.4 (57.7-77.2) 59.5 (43.2-75.7) 67.9 (54.5-81.3)
Thoughts of death/suicide 77.0 (66.9-87.1) 83.2 (77.4-88.9) 68.1 (45.1-91.0) 87.8 (80.0-95.7)
CI= confidence interval
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of recognition of depression in patients with somatic 
presentation of depressive symptomatology.10,17 The design 
of our study, in which physicians were active participants 
who were specifically trained to diagnose depression 
and to utilize PRIME-MD (which includes fatigue and 
psychomotor agitation/retardation as depressive symptoms) 
may have contributed to this high level of sensitivity. 
In our study, physicians were more likely to recognize 
fatigue and psychomotor agitation/retardation as depressive 
symptoms because of exceptional concern over missing 
a diagnosis of MDD. This worry could have overcome 
the normalizing symptom attribution described in studies 
of primary care patients.10,18-25 In previous studies, low 
sensitivity and specificity rates for recognition of somatic 
depressive symptoms have been attributed, at least in part, 
to the use of instruments that exclude somatic symptoms.10 
For example, the Hampshire Depression Project used the 
Hospital Anxiety and Depression Scale (HADS), which 
excludes somatic symptoms, to evaluate depression; it did 
not achieve a significant improvement in the recognition 
of depressive symptoms.20 However, the high rate of false 
positive results for both fatigue and psychomotor agitation/
retardation observed in our study (which used PRIME-MD, 
an instrument that captures somatic symptoms) indicates 
that the simple inclusion of somatic symptoms in the list 
of symptoms to diagnose depression may not completely 
solve the problem. The tendency of patients with low 
educational levels to over-report complaints in the absence 
of symptoms26 may lead physicians to make false positive 
diagnoses, and thus might partially explain this finding. 
The lowest sensitivity observed in our study was for 
the symptom of impaired concentration. This trend held 
true in the total sample and in the groups defined by gender 
and by the presence or absence of a medical condition. 
Although impaired concentration may also be present 
in other psychiatric disorders, it has been reported to be 
significantly and independently associated with the diagnosis 
of MDD.21 In addition, neurocognitive deficit has been 
considered an objective marker of the cerebral dysfunction 
of depression,22,23 and it has been associated with a history 
of psychiatric hospitalizations.24,27 Although the modules 
of SCID I/P and PRIME-MD for the diagnosis of MDD 
use the same criteria, they differ with respect to impaired 
concentration. Whereas PRIME-MD includes only impaired 
concentration to fulfill the criterion, SCID I/P includes 
the presence of indecision as an alternative to impaired 
concentration for fulfilling the criterion. It is possible to 
speculate that physicians consider impaired concentration 
as a relatively normal stress-related complaint and do not 
recognize it as a possible depressive symptom. However, 
because of the above-mentioned difference between PRIME-
MD and SCID-IP, we cannot exclude that this low sensitivity 
for impaired concentration results from the non-inclusion 
of indecision as an alternative for impaired concentration 
in PRIME-MD. Indecision has been reported to be a good 
marker of depression severity, independent of the presence 
of a medical illness.1,25,28 In our sample, 177 (65%) patients 
had impaired concentration or indecision according to the 
psychiatrists using SCID-IP, and the physicians missed 68 
(38%) of these cases. Our sense is that this item in PRIME-
Table 4 - Primary care physicians recognition of depressive symptoms: sensitivity and, specificity according to presence or 
not of medical illness (n=316)
Absence of medical illness  Presence of medical illness
Depressive symptoms Sensitivity 95% CI Specificity 95% CI Sensitivity 95% CI Specificity 95% CI
Depressed mood 79.2 (70.4-88.0) 54.9 (36.7-73.0) 75.2 (68.3-82.2) 67.6 (55.2-79.9)
Loss of interest/pleasure 84.8 (76.3-93.4) 43.7 (28.8-58.7) 76.4 (69.5-83.3) 63.5 (51.6-75.4)
Appetite/weight change 79.9 (70.2-89.6) 61.9 (47.7-76.2) 68.1 (60.0-76.2) 81.1 (72.4-89.7)
Insomnia/hypersomnia 78.5 (68.5-88.5) 65.2 (51.5-79.0) 72.2 (64.4-80.4) 65.8 (56.0-75.6)
Psychomotor agitation/retardation 84.0 (72.3-95.7) 38.4 (27.2-49.7) 79.8 (71.2-88.4) 48.0 (39.1-56.8)
Fatigue 85.5 (77.6-93.4) 31.4 (16.0-46.8) 84.8 (79.2-90.4) 53.1 (39.1-67.0)
Worthlessness/guilt 91.3 (83.2-99.4) 53.8 (41.7-66.0) 67.2 (57.4-76.9) 57.7 (48.7-66.7)
Impaired concentration 65.8 (54.0-77.5) 61.8 (47.9-75.7) 58.9 (50.0-67.9) 69.8 (60.3-79.3)
Thoughts of death/suicide 69.7 (54.2-85.3) 81.7 (73.1-90.4) 79.2 (67.8-90.6) 85.4 (79.9-91.0)
CI = confidence interval
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MD deserves revision, and a new version should include the 
symptoms impaired concentration and indecision. 
Physicians have a lower sensitivity for detecting 
worthlessness or guilt in patients with medical disease than 
in subjects without medical disease (67.2% versus 91.3%). 
Since the presence of a medical illness is probably not 
associated with differences in the frequency of symptoms 
used to diagnose major depressive disorder,27 our finding may 
reflect the tendency of physicians to consider psychological 
depressive symptoms (i.e., worthlessness or guilt) as normal 
psychological reactions to medical disease. Previous studies 
have reported a lower recognition of depression by general 
practitioners in patients with medical illness,28,29 and in 
patients with more severe medical illness.1,29 
Our study has some limitations that should be 
considered. First, although the 19 participant physicians 
received payment for their evaluations, we can not exclude 
the possibility that this group is overpopulated with 
physicians more interested in psychiatry and possibly more 
prone to adequately evaluate the depressive symptoms. 
The physicians were all from the HC-FMUSP, and the 
peculiarities of medical education in the undergraduate and 
resident programs restrict the generalization of our findings 
to physicians from other centers. The symptomatologic 
depressive profile of our subjects may have specificities that 
limit the generalization of our results to patients from other 
centers and units. However, the strategy of investigating the 
recognition of each specific symptom that we used in our 
study could be a promising mechanism by which to improve 
physicians’ skills for the diagnosis of depression.
In conclusion, this study of physicians using PRIME-MD 
to detect depressive symptoms compared to psychiatrists 
using SCID found low positive likelihood ratios for fatigue 
and psychomotor agitation/retardation, and low sensitivity 
for impaired concentration. These findings suggest that the 
physicians’ ability to recognize depressive symptoms may 
vary across the depressive symptomatology independent 
of their psychological or somatic nature. Thus, programs 
aiming at improving the detection of depression in medical 
settings should consider physicians’ clinical judgment, as has 
been previously proposed30 and focus on their performance 
at recognizing specific depressive symptoms. Our sense 
is that repeating the training of the participant physicians 
and discussing the results and the underlying causes of 
the discrepancies could optimize efforts and considerably 
enhance the physicians’ skills. 
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